|
RESCISSION, RESTRUCTURING
AND ASSIGNMENT AGREEMENT
This Rescission, Restructuring and Assignment Agreement (this
"AGREEMENT")
is entered into as of January 27, 2005, by and among Integrated
Healthcare
Holdings, Inc., a Nevada corporation (the "COMPANY"), Kali P.
Chaudhuri, M.D.
("DR. CHAUDHURI"), William E. Thomas ("THOMAS") (for purposes of
Sections 3 and
10 only), Anil V. Shah, M.D. ("DR. SHAH") (for purposes of
Sections 2(a) and 9
only), and Orange County Physicians Investment Network, LLC, a
Nevada limited
liability company ("OC-PIN").
R E C I T A L S
A. The Company and Dr. Chaudhuri are parties to a Secured
Convertible Note
Purchase Agreement dated as of September 28, 2004, which was
amended by a First
Amendment to Secured Convertible Note Purchase Agreement dated
as of November
16, 2004 (collectively, the "PURCHASE AGREEMENT"), pursuant to
which Dr.
Chaudhuri was issued a $500,000 Secured Convertible Promissory
Note
("CONVERTIBLE NOTE"), a $10,000,000 Secured Promissory Note
("SECURED NOTE"),
and a Stock Option Agreement dated November 16, 2004 ("STOCK
OPTION AGREEMENT").
B. The Company is in default of its obligation to repay the
Convertible
Note by December 31, 2004.
C. The Company desires that OC-PIN invest in the Company.
D. Dr. Chaudhuri and Dr. Shah, an authorized representative and
affiliate
of OC-PIN, are parties to a Non-Circumvention Agreement dated
November 11, 2004
("NON-CIRCUMVENTION AGREEMENT").
E. As a condition to investment, OC-PIN has requested that the
Convertible
Note, the Secured Note, the Stock Option Agreement and certain
provisions of the
Agreement be rescinded and canceled, and Dr. Chaudhuri
restructure his financial
arrangements with the Company, and that he terminate the
Non-Circumvention
Agreement. Dr. Chaudhuri is willing to reduce his contractual
rights and
participation and otherwise accommodate the Company and OC-PIN
on the terms and
subject to the conditions set forth in this Agreement.
F. The parties acknowledge that Dr. Chaudhuri had the right to
acquire a
majority interest in the Company, which right he has agreed
(subject to the
conditions herein) to rescind, and accept in its place stock
purchase warrants
in favor of Dr. Chaudhuri and Thomas to acquire only up to (and
not to exceed)
24.9% of the Company's capital stock, which warrants are not
exercisable for two
years from the date of issuance, and the Company and OC-PIN are
willing to
consent to this arrangement.
G. The Company is a party to a definitive Asset Sale Agreement,
dated
September 29, 2004 (the "ASSET SALE AGREEMENT"), pursuant to
which the Company
has agreed to purchase four hospitals from subsidiaries of Tenet
Healthcare
Corporation located in Orange County, California, known as
Western Medical
Center - Santa Ana, Western Medical Center - Anaheim, Costal
Communities
Hospital, and Chapman Medical Center. The transactions
contemplated under the
Asset Sale Agreement are collectively referred to herein as the
"TENET
TRANSACTION".
1
<PAGE>
H. The Tenet Transaction has not yet closed, and the parties
desire to
reflect and memorialize certain understandings among them with
respect to the
Tenet Transaction. This Agreement is expressly conditioned upon
Tenet's
acceptance of the restructuring contemplated by this Agreement
and its release
of Dr. Chaudhuri from his guarantee of the Chapman lease.
A G R E E M E N T
In consideration of the foregoing premises, the mutual covenants
and
agreements set forth herein, and for other good and valuable
consideration, the
receipt and sufficiency of which are hereby acknowledged, and
subject to
satisfaction of the conditions set forth in Section 9, the
parties hereto hereby
agree as follows:
1. DEFINITIONS. For the purposes of this Agreement (including
amendments
to the Purchase Agreement contained herein), (i) unless
otherwise set forth
herein, capitalized terms or matters of construction deemed or
established in
the Purchase Agreement, as amended hereby, shall be applied
herein as defined or
established therein, and (ii) the term "FULLY-DILUTED" includes
all shares of
Common Stock of the Company issued and outstanding at the date
in question plus
all shares of Common Stock of the Company issuable (whether or
not vested) at
that date upon full exercise of all options, warrants or other
rights to acquire
Common Stock of the Company and full conversion of all
securities convertible
into Common Stock of the Company, but excluding from that amount
up to
10,000,000 shares (or rights to acquire shares) of Common Stock
per year to
employees, consultants, officers or directors of the Company
pursuant to stock
option or restricted stock plans or agreements approved by the
Company's Board
of Directors.
2. RESCISSION AND CANCELLATION OF NOTES, OPTION,
NON-CIRCUMVENTION
AGREEMENT AND CERTAIN PROVISIONS OF PURCHASE AGREEMENT.
(a) Upon fulfillment of the conditions set forth in Section 9,
the
Convertible Note, the Secured Note, the Stock Option Agreement
and the
Non-Circumvention Agreement are hereby rescinded and canceled.
Within two (2)
business days after receipt of the $10,000,000 plus accrued
interest referred to
in Section 6, Dr. Chaudhuri shall, and he shall cause his
attorneys and agents
to, (i) return to the Company the originals of the Convertible
Note and the
Secured Note for cancellation and (ii) deliver to OC-PIN copies
of all material
agreements executed by Dr. Chaudhuri with the Company or in
connection with the
Tenet Transaction. Except as provided in this Agreement with
respect to Thomas,
Dr. Chaudhuri hereby represents and warrants to the Company that
he has not,
directly or indirectly, transferred, sold or syndicated any part
of the
securities that he received or was entitled to acquire from the
Company.
(b) The Purchase Agreement is hereby rescinded and canceled,
except
that the provisions of: (i) Section 1.7 thereof shall remain in
effect (as
amended by Section 4 below) (ii) Article II thereof shall remain
in effect (as
amended by Section 4 below) and shall be applicable to the
shares of the
Company's Common Stock issuable pursuant to the warrants
described in Section 3
below; (iii) Articles III and IV thereof shall remain in effect
and the
provisions thereof shall be deemed to apply with respect to the
issuances
described in Section 3 below; and (iv) Section 5.3 thereof shall
remain in
effect for the benefit of both Dr. Chaudhuri and Thomas for so
long as either of
them holds either stock purchase warrants pursuant to the new
warrants described
in Section 3 below or shares of the Company's Common Stock
obtained by them upon
exercise thereof, provided, however that (A) Section 5.3 shall
terminate and
cease to have effect upon an acquisition of the Company by an
unrelated third
party and (B) each of Dr. Chaudhuri and Thomas shall execute
appropriate
confidentiality agreements in customary form with respect to
information
obtained pursuant to these sections.
2
<PAGE>
(c) Dr. Chaudhuri agrees to reasonably cooperate with the
Company
and California Department of Health Services at no or minimal
cost to Dr.
Chaudhuri by providing information and other reasonable
assistance so that the
Company may promptly complete the Tenet Transaction and obtain
licensing of the
hospital facilities to be acquired therein; provided that such
cooperation shall
not result in any material modification to this Agreement.
3. ISSUANCE OF NEW NON-CONVERTIBLE NOTES AND WARRANTS;
ASSIGNMENT TO
THOMAS. The Company has agreed to issue to Dr. Chaudhuri (i) a
new
non-convertible secured promissory note reflecting amounts
loaned to the Company
by Dr. Chaudhuri as well as expenditures made by Dr. Chaudhuri
on the Company's
behalf or for the Company's benefit, plus accrued interest to
date, and (ii) a
new stock purchase warrant reflecting the right to purchase
shares of the
Company's Common Stock. Dr. Chaudhuri has assigned to Thomas
certain of his
rights with respect thereto, to which assignments the Company
and OC-PIN hereby
consent. As a result of the assignment, the parties acknowledge
and agree that,
within 48 hours after the execution of this Agreement, but dated
and effective
as of the date of this Agreement, the Company shall issue to (A)
Dr. Chaudhuri a
non-convertible secured promissory note, in substantially the
form of Exhibit
A-1, and in a principal amount equal to 80% of the sum of all
amounts loaned by
Dr. Chaudhuri to the Company or paid, advanced or incurred by
Dr. Chaudhuri on
behalf or for the benefit of the Company, or in connection with
the Purchase
Agreement and related documents, or in connection with the Tenet
Transaction
(collectively, the "ADVANCES"), (B) Thomas a non-convertible
secured promissory
note, in substantially the form of Exhibit A-2, and in a
principal amount equal
to 20% of the Advances (collectively, the "NEW NOTES"), (C) Dr.
Chaudhuri a
stock purchase warrant reflecting the right to purchase up to
60,000,000 shares
of the Company's Common Stock (but not to exceed 20% of the
Company's
Fully-Diluted capital stock) in substantially the form of
Exhibit B-1 and (D)
Thomas a stock purchase warrant reflecting the right to purchase
up to
14,700,000 shares of the Company's Common Stock (but not to
exceed 4.9% of the
Company's Fully-Diluted capital stock) in substantially the form
of Exhibit B-2
(collectively, the "NEW WARRANTS"). Repayment of the New Notes
shall be
guaranteed by OC-PIN pursuant to a General Continuing Guaranty
substantially in
the form of Exhibit C.
4. CERTAIN AMENDMENTS.
(a) Section 1.7 of the Purchase Agreement is hereby amended
by
deleting it in its entirety and replacing it with the
following:
3
<PAGE>
"1.7 PRE-EMPTIVE RIGHTS.
1.7.1 GENERAL PRE-EMPTIVE RIGHT. Provided that Purchaser and
William E. Thomas ("THOMAS") have exercised their Stock
Purchase
Warrants dated January 17, 2005, the Company hereby grants
to
Purchaser and Thomas a right of first refusal with respect to
future
sales by the Company of its equity securities or securities
convertible into or exercisable for equity securities, where
issuance of those securities would result in dilution of
Purchaser's
and Thomas's combined equity position to less than 24.9% of
the
Common Stock of the Company on a Fully-Diluted basis. Each time
the
Company proposes to offer any shares of, or securities
convertible
into or exercisable for any shares of, any class of the
Company's
equity securities which would reduce Purchaser's and
Thomas's
combined equity position to below 24.9% (the "NEW SHARES"),
the
Company shall first make an offer to Purchaser and Thomas of
such
portion of the New Shares which would maintain Purchaser's
and
Thomas's combined equity position at a minimum of 24.9% (the
"PRO
RATA SHARE"). The closing of the sale of the Pro Rata Share
shall
occur simultaneously with the sale of the New Shares to
other
investors, and the Pro Rata Share shall be priced equal to
the
lowest price paid by any of the other investors, including any
who
may be purchasing New Shares by virtue of similar pre-emptive
or
other purchase rights.
1.7.2 TAG-ALONG RIGHT RELATING TO OC-PIN. The Company hereby
grants to Purchaser and Thomas a purchase right with respect
to
future issuances by the Company of any of its securities to Anil
V.
Shah, M.D. or Orange County Physicians Investment Network,
or
affiliates of either of them (collectively, "OC-PIN GROUP"),
where
the issuance of such additional shares of Common Stock would
result
in the OC-PIN Group having been issued, in the aggregate, more
than
187,240,000 shares of the Company's Common Stock on a
Fully-Diluted
basis (as adjusted for any stock splits, dividends, combinations
or
the like). Upon satisfaction of these conditions, Purchaser
and
Thomas shall have the right to acquire, for a period of 90
days
following notification by the Company to Purchaser and Thomas
that
the pre-emptive right is triggered (which notice shall be
given
within 10 business days of such trigger), the same securities,
and
at the same price, as the member of the OC-PIN Group purchasing
the
Company's securities, in an amount that represents the same
proportion as Purchaser's and Thomas's combined holdings of
the
Company's Common Stock on a Fully-Diluted basis bears to the
OC-PIN
Group's combined holdings of the Company's Common Stock on a
Fully-Diluted basis immediately prior to the issuance in
question.
1.7.3 EXCLUSIONS. The rights in this Section 1.7 shall not
be
applicable to the issuance or sale of (i) securities issued
pursuant
to stock splits, stock dividends, or similar transactions;
(ii)
shares of Common Stock issued to employees, consultants,
officers or
directors of the company pursuant to stock option plans or
restricted stock plans or agreements approved by the Company's
Board
of Directors; (iii) securities issued to financial institutions
or
lessors in connection with commercial credit arrangements,
equipment
financings, commercial property lease transactions, or
similar
transactions approved by the Board of Directors and not for
the
purpose of raising capital, (iv) shares of Common Stock issued
in an
underwritten public offering; or (v) securities issued in
connection
with bona fide acquisition transactions approved by the Board
of
Directors.
4
<PAGE>
1.7.4 TERMINATION. The pre-emptive rights in this Section
1.7
shall terminate and cease to have effect upon the earlier of (i)
the
closing of an acquisition of the Company to an unrelated third
party
or (ii) the later of one-half (3 1/2) years from the date of
this
Agreement or the termination of any similar pre-emptive
rights
granted to OC-PIN or its affiliates."
(b) Article II of the Purchase Agreement is hereby amended
to
reflect that references to "Purchaser" or "the Holder" shall now
mean Dr.
Chaudhuri and Thomas. The definition of "REGISTRABLE SECURITIES"
contained in
Section 2.1 of the Purchase Agreement is hereby deleted in its
entirety and
replaced with the following:
"`REGISTRABLE SECURITIES' means, collectively, any shares of
common
stock of the Company issued to Kali P. Chaudhuri, M.D. or
William E.
Thomas pursuant to Stock Purchase Warrants issued to those
individuals on January 17, 2005, and any securities issued
or
issuable upon any stock dividend, stock split,
recapitalization,
merger, consolidation or similar event with respect to such
shares
of common stock. As to any particular Registrable Securities,
such
securities shall cease to be Registrable Securities when (i)
a
registration statement covering such securities shall have
become
effective under the 1933 Act and such securities shall have
been
disposed of in accordance with such registration statement,
(ii)
such securities shall have been distributed to the public, or
all
such securities may be sold publicly without registration,
pursuant
to Rule 144 or Rule 144A (or any successor provisions ) under
the
1933 Act, or (iii) such securities shall have ceased to be
outstanding."
5. AMENDMENT OF SECURITY AGREEMENT. The Security Agreement
between the
Company and Dr. Chaudhuri dated September 28, 2004, is hereby
amended to provide
that the secured parties are Dr. Chaudhuri and Thomas, and that
the obligations
secured are the obligations under the New Notes and any other
obligations of the
Company to Dr. Chaudhuri arising thereunder or under this
Agreement; however,
the security interest securing the New Notes shall be terminated
effective at
the closing of the Tenet Transaction. Dr. Chaudhuri (and Thomas
if necessary)
shall execute and, if requested by the Company and the lender in
the Tenet
Transaction, deliver to the escrow agent for the Tenet
Transaction an executed
UCC termination statement to accomplish the foregoing.
5
<PAGE>
6. PAYMENT TO DR. CHAUDHURI; CERTAIN DISCLAIMERS. On the date of
approval
of this Agreement by Tenet as contemplated by Section 9, OC-PIN
shall pay, or
shall cause the Company to pay, or shall cause to be released
from the Escrow
Fund, $10,000,000 plus the accrued interest in the Escrow Fund
to Dr. Chaudhuri,
in immediately available funds. Nothing in this Agreement or any
of the exhibits
hereto shall be effective or of any force and effect until Dr.
Chaudhuri has
received this payment of $10,000,000 plus accrued interest. Any
agreements or
arrangements between OC-PIN and the Company with respect to this
payment of
$10,000,000 plus accrued interest shall be pursuant to a
separate agreement
between them, and Dr. Chaudhuri shall have no involvement
therewith or
responsibility therefor. Furthermore, Dr. Chaudhuri makes, and
the Company and
OC-PIN expressly acknowledge that Dr. Chaudhuri has made, no
representations or
warranties to OC-PIN or the Company or any of their affiliates
regarding the
Company, OC-PIN, OC-PIN's financial wherewithal, the Tenet
Transaction, the
financing related to the Tenet Transaction (or the Company's
ability to obtain
it), licensing (or the Company's ability to obtain it) or any
other matter
relating in any way to OC-PIN's investment in or other financial
arrangements
with the Company. Each of the Company and OC-PIN has done its
own independent
investigation of the other, and is fully satisfied with the
results of those
investigations. The Company and OC-PIN hereby agree to
indemnify, defend and
hold Dr. Chaudhuri harmless from and against any claims,
liabilities or losses
incurred by either of them as a result of the financial or other
arrangements
between them.
7. AMENDMENT AND EXERCISE OF AMENDED AND RESTATED REAL ESTATE
PURCHASE
OPTION. Pursuant to Section 3 of the Option Agreement dated
September 28, 2004,
as amended and restated on November 16, 2004 ("LLC OPTION
AGREEMENT"), Dr.
Chaudhuri currently has an option to purchase 100% of the
membership interests
of the LLC (as defined in the LLC Option Agreement) for
$5,000,000. The LLC
Option Agreement is hereby amended to provide that Dr.
Chaudhuri's option shall
be to purchase 49% of the membership interests of the LLC for
$2,450,000, and
may be assigned to and exercised by an affiliate of Dr.
Chaudhuri. Dr. Chaudhuri
hereby exercises that option, as so amended, such exercise to be
conditioned
upon, and effective at, the Closing (as defined in the Asset
Sale Agreement) of
the Tenet Transaction. The exercise is also conditioned upon (a)
receipt by Dr.
Chaudhuri of receipt of evidence satisfactory to him that OC-PIN
has acquired
the remaining 51% of the LLC membership interests simultaneously
with Dr.
Chaudhuri's acquisition of the 49% interest, (b) receipt by Dr.
Chaudhuri of
receipt of evidence satisfactory to him that the LLC has
acquired the real
estate (owned in fee) in the Tenet Transaction (i.e. Western
Medical Center -
Santa Ana, Western Medical Center - Anaheim and Coastal
Community Hospital and
the medical office buildings, but not the leased Chapman
Hospital and medical
office building), (c) execution by Dr. Chaudhuri, OC-PIN and Dr.
Shah, and by
the Company if initially required, of a customary Operating
Agreement for a
California manager-managed limited liability company reasonably
satisfactory to
Dr. Chaudhuri and OC-PIN in which (i) Dr. Chaudhuri and Dr. Shah
have equal
rights of management of the LLC, and (ii) Dr. Chaudhuri may not
sell, syndicate
or otherwise transfer any of his management rights in the LLC
without the
consent of the holder(s) of a majority of the LLC membership
interests (although
it is expressly understood that Dr. Chaudhuri may hold title to
the LLC
membership interests through an affiliate), and (d) execution by
the Company, as
tenant, of a lease with the LLC, as landlord, in substantially
the form of
Exhibit D. The exercise price shall be placed into escrow and
released against
delivery of certificates or other satisfactory evidence of
transfer to Dr.
Chaudhuri or an affiliate of 49% of the membership interests of
the LLC. The
Company and OC-PIN agree to comply with all of the aforesaid
covenants which
may, at Dr. Chaudhuri's election, be specifically enforced as
provided in
Section 11.6.
6
<PAGE>
8. CERTAIN AGREEMENTS RELATED TO TENET TRANSACTION AND RELATED
FINANCING.
The parties have agreed as follows with respect to the Tenet
Transaction and the
proposed $80,000,000 credit facility ("FACILITY") from Company's
current Lender,
or other lender agreeable to the parties ("LENDER") related
thereto:
(a) The Company and the LLC shall be co-borrowers with respect
to
the Facility, with the Company and the LLC each fully liable for
the entire
amount borrowed thereunder.
(b) The Company and the LLC will enter into a mutually
acceptable
inter-borrower and cross-indemnity agreement.
(c) If requested by the Lender, the Lender will have a
security
interest not only in all of the assets of the Company and the
LLC, but also in
all LLC membership interests and in the master lease from the
LLC to the
Company.
9. CONDITIONS PRECEDENT. This Agreement, and specifically Dr.
Chaudhuri's
and Thomas's obligations hereunder, are expressly conditioned
upon Tenet's
acceptance of the restructuring and other terms set forth
herein, and, because
Dr. Chaudhuri is rescinding his right to receive any interest in
the Chapman
Hospital real estate, upon Tenet's release of Dr. Chaudhuri's
guarantee in
Tenet's favor of the tenant's obligations under the Chapman
Hospital lease. Dr.
Shah shall provide his personal guarantee of the tenant's
obligations in place
of that of Dr. Chaudhuri, in a for substantially identical to
the form of
guaranty provided by Dr. Chaudhuri to Tenet. The provisions of
this Agreement,
including the exhibits hereto, shall only be effective upon (i)
receipt by Dr.
Chaudhuri of written evidence reasonably satisfactory to him,
and executed by
Tenet, setting forth Tenet's acceptance and release as described
above, (ii)
receipt by Dr. Chaudhuri of the payment of $10,000,000 plus
accrued interest
referred to in Section 6, (iii) receipt by Dr. Chaudhuri and
Thomas of fully
executed originals of the New Notes and New Warrants, and (iv)
execution and
delivery of a mutually agreeable Operating Agreement for the LLC
pursuant to
Section 7 above. If all of the foregoing conditions are not
fully satisfied by
5:00 p.m. on January 31, 2005, Dr. Chaudhuri shall be entitled
to terminate this
Agreement, in which case nothing in this Agreement, including
all rescissions,
amendments and restructurings, shall be of any force or
effect.
10. MUTUAL RELEASE. Except with respect to obligations created
in or
expressly continued by this Agreement and in the New Warrants
and New Notes,
each of Dr. Chaudhuri and Thomas, on the one hand, and the
Company and OC-PIN,
on the other hand, on behalf of themselves and their successors
and assigns,
hereby release and discharge the other and the other's
representatives,
officers, directors, agents, employees, attorneys, successors
and assigns from
any claims, demands, actions, causes of action, losses and
liabilities of any
kind or nature whatsoever that the party may have, may have had
in the past, or
may have in the future, whether known or unknown, suspected or
unsuspected, now
due or contingent, to the full extent that any such claim,
demand, action, cause
of action, loss or liability arises out of or is in any way
related to the
Purchase Agreement, the Convertible Note, the Secured Note, the
Stock Option
Agreement, the Tenet Transaction or OC-PIN's investment in or
other financial
arrangements with the Company. Each of the parties hereby
acknowledges and
agrees that he or it is aware of, has read, has had explained to
him or it by
independent counsel of his or its own choosing, understands, and
hereby waives
the provisions of California Civil Code Section 1542, which
reads:
7
<PAGE>
A general release does not extend to claims which the creditor
does
not know or suspect to exist in his favor at the time of
executing
the release, which, if known by him must materially have
affected
his settlement with the debtor.
Dr. Chaudhuri also agrees to release the individual members of
the Medical
Staff, as that term is defined in the Agreement dated as of
January 25, 2005
among the Company, Dr. Chaudhuri, Chapman Medical Center, Inc.,
Coastal
Communities Hospital, Inc.; WMCA, Inc. and WMC-SA, Inc. and the
Medical Staff of
Western Medical Center - Santa Ana, an unincorporated
association (the "STAFF
AGREEMENT"), as more specifically set forth in Section 11 of the
Staff
Agreement.
11. MISCELLANEOUS.
11.1 AMENDMENT. This Agreement may be modified or amended only
by
mutual written agreement of the parties. Any such modification
or amendment must
be in writing, dated and signed by the parties and attached to
this Agreement.
11.2 BINDING EFFECT. Subject to the foregoing, this Agreement
shall
be binding on and shall inure to the benefit of the parties and
their respective
successors and assigns.
11.3 ATTORNEYS' FEES. In any action or dispute, at law or in
equity,
that may arise under or otherwise relate to this Agreement, the
prevailing party
shall be entitled to the award of reasonable attorneys' fees and
costs, in
addition to whatever relief the prevailing party may be awarded;
provided,
however, that so long as the present Company Board of Directors
remains in
place, the parties agree to bear their own fees and costs in the
event of any
dispute.
11.4 VENUE. The parties agree that Orange County, California
shall
be the only proper venue for disputes related to this
Agreement.
11.5 ENTIRE AGREEMENT. This Agreement, along with the New Notes,
New
Warrants and General Continuing Guaranty, and the Purchase
Agreement and the
Security Agreement, as amended hereby, represents the entire
understanding and
agreement of the parties regarding its subject matter, and
supersedes any prior
oral or written agreements, representations, understandings or
discussions
between the parties. No other understanding between the parties
shall be binding
on them unless set forth in writing and signed by the party
against whom the
understanding is to be enforced.
11.6 SPECIFIC PERFORMANCE. The parties acknowledge that the
LLC
membership interests, the real estate to be acquired by the LLC,
the New Notes
and the New Warrants are unique, and that damages would not be
an adequate
remedy for Dr. Chaudhuri and Thomas in the event of the
Company's or OC-PIN's
failure to perform any of their obligations hereunder and under
the New Warrants
(including, without limitation, its obligation to deliver the
Shares if Dr.
Chaudhuri or Thomas elects to exercise his New Warrant). As a
result, the
parties agree that this Agreement may be enforced by any party
by specific
performance.
8
<PAGE>
11.7 GOVERNING LAW. This Agreement shall be construed in
accordance
with and governed by the laws of the State of California, except
the conflicts
of laws provisions that would require the application of the
laws of any other
jurisdiction.
11.8 HEADINGS. The headings in this Agreement are intended
solely
for convenience of reference and shall be given no effect in the
construction or
interpretation of this Agreement.
11.9 MEANING OF CERTAIN WORDS. Wherever the context may require,
any
pronouns used in this Agreement shall include the corresponding
masculine,
feminine, or neuter forms, and the singular form of nouns shall
include the
plural and vice versa.
11.10 NO THIRD-PARTY BENEFICIARY RIGHTS. The parties do not
intend
to confer and this Agreement shall not be construed to confer
any rights or
benefits to any person, firm, corporation or entity other than
the parties.
11.11 NOTICES. All notices or communications required or
permitted
under this Agreement shall be given in writing and delivered
personally or sent
by United States registered or certified mail with postage
prepaid and return
receipt requested or by overnight delivery service (e.g.,
Federal Express, DHL).
Notice shall be deemed given when sent, if sent as specified in
this Section, or
otherwise deemed given when received. In each case, notice shall
be delivered or
sent to:
IF TO COMPANY, ADDRESSED TO:
Integrated Healthcare Holdings, Inc.
695 Town Center Drive, Suite 260
Costa Mesa, CA 92626
Attention: Chief Executive Officer
IF TO DR. CHAUDHURI OR TO THOMAS, ADDRESSED TO:
c/o Strategic Global Management, Inc.
6800 Indiana Avenue, Suite 130
Riverside, CA 92506
Attention: William E. Thomas, Esq.
IF TO DR. SHAH OR TO OC-PIN, ADDRESSED TO:
c/o Orange County Physicians Investment Network, LLC
2621 S. Bristol Street, Suite 108
Santa Ana, CA 92704
Attention: Anil V. Shah, Manager
11.12 SEVERABILITY. If any provision of this Agreement is
determined
to be illegal or unenforceable, that provision shall be severed
from this
Agreement, and such severance shall have no effect upon the
enforceability of
the remainder of this Agreement.
9
<PAGE>
11.13 WAIVER. No delay or failure to require performance of
any
provision of this Agreement shall constitute a waiver of that
provision as to
that or any other instance. Any waiver granted by a party must
be in writing to
be effective, and shall apply solely to the specific instance
expressly stated.
11.14 CONFIDENTIALITY. Neither party shall disclose any of the
terms
of this Agreement to any person or entity (other than its
attorneys or
accountants) without the prior written consent of the other
party, unless and
only to the extent such disclosure is required by law, including
the 1933 Act.
11.15 DISPUTE RESOLUTION. In the event of any dispute arising
out of
or relating to this Agreement, such dispute shall be resolved
solely and
exclusively by confidential binding arbitration with the Orange
County branch of
JAMS ("JAMS") to be governed by JAMS' Commercial Rules of
Arbitration in effect
at the time of the commencement of the arbitration (the "JAMS
RULES") and heard
before one arbitrator. The parties shall attempt to mutually
select the
arbitrator. In the event they are unable to mutually agree, the
arbitrator shall
be selected by the procedures prescribed by the JAMS Rules.
11.16 COUNTERPARTS. This Agreement may be executed in one or
more
counterparts, each of which shall be deemed to be an original,
and all of which
together shall constitute one and the same instrument.
* * *
[SIGNATURES ON FOLLOWING PAGE]
10
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be
executed and delivered as of the date first written above.
THE COMPANY: INTEGRATED HEALTHCARE HOLDINGS,
INC., a Nevada corporation
By: /s/ Larry B. Anderson
-------------------------------------
Larry B. Anderson, President
DR. CHAUDHURI: /s/ Kali P. Chaudhuri
-----------------------------------------
KALI P. CHAUDHURI, M.D.
OC-PIN: ORANGE COUNTY PHYSICIANS
INVESTMENT NETWORK, LLC, a Nevada
limited liability company
By: /s/ Anil V. Shah
-------------------------------------
Anil V. Shah, M.D., Manager
For purposes of Sections 3 and 10 only:
I hereby accept the assignment of a portion of Dr. Chaudhuri's
rights as set
forth in Section 3, and agree to be bound by the provisions of a
Stock Purchase
Warrant substantially in the form attached hereto as Exhibit
B-2, and by the
provisions of Section 10. Except as expressly set forth above, I
am not a party
to this Agreement and have given no representations, warranties
or assurances to
any person.
THOMAS: /s/ William E. Thomas
-----------------------------------------
WILLIAM E. THOMAS
For purposes of Sections 2(a) and 9 only:
I hereby agree to the rescission of the Non-Circumvention
Agreement on the terms
and conditions set forth in Section 2(a), and to providing a
personal guarantee
as set forth in Section 9. Except as expressly set forth above,
I am not a party
to this Agreement and have given no representations, warranties
or assurances to
any person.
DR. SHAH /s/ Anil V. Shah
-----------------------------------------
ANIL V. SHAH, M.D.
11
<PAGE>
Approved as to form:
----------------------------------------
Gregg Amber, Esq. of Rutan & Tucker, LLP
attorneys for Dr. Chaudhuri
----------------------------------------
Allen Z. Sussman, Esq. of Morrison &
Foerster, LLP
attorneys for the Company
----------------------------------------
Hari S. Lal, Esq. of The Lal Law Firm,
Inc.
attorneys for Dr. Shah and OC-PIN
12
<PAGE>
EXHIBIT A-1
FORM OF
NON-CONVERTIBLE NOTE
$__________ Costa Mesa, California
January 27, 2005
SECURED PROMISSORY NOTE
FOR VALUE RECEIVED, the undersigned, INTEGRATED HEALTHCARE
HOLDINGS, INC.,
a Nevada corporation (the "COMPANY"), promises to pay to the
order of Kali P.
Chaudhuri, M.D. ("HOLDER"), at c/o 6800 Indiana Avenue, Suite
130, Riverside,
California 92506, or at such other location as is designated by
Holder in
writing hereunder, the aggregate sum of ________________ Dollars
($_______),
bearing simple interest on the unpaid principal balance of this
Note, from the
date of this Note until this Note is paid in full at a rate of
five percent
(5.0%) per annum. Accrued interest shall be computed based on
the actual number
of days elapsed. Interest only shall be payable on the first
Business Day of
each calendar month beginning February 1, 2005. All principal
and accrued but
unpaid interest will be due and payable in full at the Closing
of the Tenet
Transaction, or on demand at any time after February 28, 2005 if
the Tenet
Transaction has not closed by that date (the "DUE DATE"). All
payments shall be
made in lawful money of the United States, without offset,
deduction, or
counterclaim of any kind.
1. TERMS. Capitalized terms used herein without definition have
the
meanings ascribed to them in the Rescission, Restructuring and
Assignment
Agreement of even date herewith by and among the Company, Holder
and certain
other parties thereto.
2 PAYMENTS AND COMPUTATIONS. All payments on account of
indebtedness
evidenced by this Note shall be made not later than 11:00 A.M.
(California time)
on the day when due in lawful money of the United States and
shall be first
applied to interest due on the unpaid principal balance and the
remainder to any
principal due. Payments are to be made at such place as Holder
or any legal
holder of this Note may, from time to time, in writing specify,
and in the
absence of a specification, at the principal place of business
of Holder as set
forth in the first paragraph of this Note. The Company may
pre-pay the full
amount of all principal of and accrued interest under this Note
at any time
without premium or penalty.
3. SECURITY. Repayment of this Note is secured pursuant to the
terms of a
Security Agreement dated September 28, 2004, and is guarantied
by a Continuing
General Guaranty dated January 27, 2005 by Orange County
Physicians Investment
Network, LLC.
4. ATTORNEYS' FEES. If any action is instituted on this Note,
the
successful or prevailing party or parties shall be entitled to
recover
reasonable attorneys' fees and other costs incurred in that
action or
proceeding, in addition to any other relief to which the party
or parties may be
entitled. Diligence, demand, presentment, notice of dishonor,
and protest are
waived by the Company, and any and all makers, sureties,
guarantors, and
endorsers of this Note, and their successors and assigns. Time
is of the essence
for every obligation under this Note.
1
<PAGE>
6. LAW. This Note shall be construed under the laws of the State
of
California, as such laws are applied to contracts entered into
and performed
entirely within that state by residents thereof.
7. RULES OF CONSTRUCTION/REPRESENTATION. The parties agree that
they are
sophisticated business persons or entities who have had the
opportunity to be
represented by counsel during the negotiation and execution of
this Note and,
therefore, waive the application of any law, regulation, holding
or rule of
construction providing that ambiguities in an agreement or other
document will
be construed against the party drafting such agreement or
document.
8. DISPUTE RESOLUTION. In the event of any dispute arising out
of or
relating to this Note, such dispute shall be resolved solely and
exclusively by
confidential binding arbitration with the Orange County branch
of JAMS ("JAMS")
to be governed by JAMS' Commercial Rules of Arbitration in
effect at the time of
the commencement of the arbitration (the "JAMS RULES") and heard
before one
arbitrator. The parties shall attempt to mutually select the
arbitrator. In the
event they are unable to mutually agree, the arbitrator shall be
selected by the
procedures prescribed by the JAMS Rules. Each party shall bear
its own
attorneys' fees, expert witness fees, and costs incurred in
connection with any
arbitration.
IN WITNESS WHEREOF, the Company has executed and delivered this
Note as of
the day and year and at the place first above written.
INTEGRATED HEALTHCARE HOLDINGS, INC.
By:
--------------------------------------
Larry B. Anderson, President
2
<PAGE>
EXHIBIT A-2
FORM OF
NON-CONVERTIBLE NOTE
$__________ Costa Mesa, California
January 27, 2005
SECURED PROMISSORY NOTE
FOR VALUE RECEIVED, the undersigned, INTEGRATED HEALTHCARE
HOLDINGS, INC.,
a Nevada corporation (the "COMPANY"), promises to pay to the
order of William E.
Thomas ("HOLDER"), at c/o 6800 Indiana Avenue, Suite 130,
Riverside, California
92506, or at such other location as is designated by Holder in
writing
hereunder, the aggregate sum of ________________ Dollars
($_______), bearing
simple interest on the unpaid principal balance of this Note,
from the date of
this Note until this Note is paid in full at a rate of five
percent (5.0%) per
annum. Accrued interest shall be computed based on the actual
number of days
elapsed. Interest only shall be payable on the first Business
Day of each
calendar month beginning February 1, 2005. All principal and
accrued but unpaid
interest will be due and payable in full at the Closing of the
Tenet
Transaction, or on demand at any time after February 28, 2005 if
the Tenet
Transaction has not closed by that date (the "DUE DATE"). All
payments shall be
made in lawful money of the United States, without offset,
deduction, or
counterclaim of any kind.
1. TERMS. Capitalized terms used herein without definition have
the
meanings ascribed to them in the Rescission, Restructuring and
Assignment
Agreement of even date herewith by and among the Company, Holder
and certain
other parties thereto.
2 PAYMENTS AND COMPUTATIONS. All payments on account of
indebtedness
evidenced by this Note shall be made not later than 11:00 A.M.
(California time)
on the day when due in lawful money of the United States and
shall be first
applied to interest due on the unpaid principal balance and the
remainder to any
principal due. Payments are to be made at such place as Holder
or any legal
holder of this Note may, from time to time, in writing specify,
and in the
absence of a specification, at the principal place of business
of Holder as set
forth in the first paragraph of this Note. The Company may
pre-pay the full
amount of all principal of and accrued interest under this Note
at any time
without premium or penalty.
3. SECURITY. Repayment of this Note is secured pursuant to the
terms of a
Security Agreement dated September 28, 2004, and is guarantied
by a Continuing
General Guaranty dated January 27, 2005 by Orange County
Physicians Investment
Network, LLC.
4. ATTORNEYS' FEES. If any action is instituted on this Note,
the
successful or prevailing party or parties shall be entitled to
recover
reasonable attorneys' fees and other costs incurred in that
action or
proceeding, in addition to any other relief to which the party
or parties may be
entitled. Diligence, demand, presentment, notice of dishonor,
and protest are
waived by the Company, and any and all makers, sureties,
guarantors, and
endorsers of this Note, and their successors and assigns. Time
is of the essence
for every obligation under this Note.
1
<PAGE>
6. LAW. This Note shall be construed under the laws of the State
of
California, as such laws are applied to contracts entered into
and performed
entirely within that state by residents thereof.
7. RULES OF CONSTRUCTION/REPRESENTATION. The parties agree that
they are
sophisticated business persons or entities who have had the
opportunity to be
represented by counsel during the negotiation and execution of
this Note and,
therefore, waive the application of any law, regulation, holding
or rule of
construction providing that ambiguities in an agreement or other
document will
be construed against the party drafting such agreement or
document.
8. DISPUTE RESOLUTION. In the event of any dispute arising out
of or
relating to this Note, such dispute shall be resolved solely and
exclusively by
confidential binding arbitration with the Orange County branch
of JAMS ("JAMS")
to be governed by JAMS' Commercial Rules of Arbitration in
effect at the time of
the commencement of the arbitration (the "JAMS RULES") and heard
before one
arbitrator. The parties shall attempt to mutually select the
arbitrator. In the
event they are unable to mutually agree, the arbitrator shall be
selected by the
procedures prescribed by the JAMS Rules. Each party shall bear
its own
attorneys' fees, expert witness fees, and costs incurred in
connection with any
arbitration.
IN WITNESS WHEREOF, the Company has executed and delivered this
Note as of
the day and year and at the place first above written.
INTEGRATED HEALTHCARE HOLDINGS, INC.
By:
--------------------------------------
Larry B. Anderson, President
2
<PAGE>
EXHIBIT B-1
FORM OF
STOCK PURCHASE WARRANT
60,000,000 Shares January 27, 2005
This certifies that, for good and valuable consideration,
receipt of which
is hereby acknowledged, Kali P. Chaudhuri, M.D. (the "HOLDER")
is entitled to
purchase, subject to the terms and conditions of this Warrant,
from Integrated
Healthcare Holdings, Inc, a Nevada corporation (the "COMPANY"),
Sixty Million
(60,000,000) shares of the Company's common stock (the "SHARES")
in accordance
with Section 3 during the period commencing on the second
anniversary of the
date hereof (the "COMMENCEMENT DATE") and ending at 5:00 p.m.
California time,
on the date which is three and one-half (3 1/2) years from the
date hereof (the
"EXPIRATION DATE"), at which time this Warrant will expire and
become void
unless earlier terminated as provided herein. Notwithstanding
the foregoing,
this Warrant may not be exercised in an amount that would
exceed, when added to
the number of shares of common stock of the Company previously
acquired by the
Holder by virtue of exercise of this Warrant (or any replacement
Warrant),
twenty percent (20%) of the total number of outstanding shares
of capital stock
of the Company on a Fully-Diluted basis on the date of exercise.
Capitalized
terms used herein without definition have the meanings ascribed
to them in the
Rescission, Restructuring and Assignment Agreement of even date
herewith by and
among the Company, the Holder and certain other parties
thereto.
1. VESTING AND EXERCISE PRICE.
(a) The right to exercise this Warrant shall fully vest on
the
Commencement Date.
(b) The exercise or purchase price for the first 34,538,153
Shares
purchased upon exercise of this Warrant shall be $0.003125 per
Share, and
the exercise or purchase price for the remainder of the Shares
shall be
$0.078 per Share if exercised between January 27, 2007 and July
26, 2007,
$0.11 per Share if exercised between July 27, 2007 and January
26, 2008,
and $0.15 thereafter, all subject to adjustment as provided in
Section 2
(the "EXERCISE PRICE").
2. ANTI-DILUTION PROVISIONS. The Exercise Price in effect at any
time and
the number of Shares purchasable upon the exercise of this
Option shall be
subject to adjustment from time to time upon the happening of
any of the
following events:
(a) If at any time the Company subdivides its outstanding shares
of
Common Stock into a greater number of shares, the Exercise Price
in effect
immediately prior to such subdivision shall be proportionately
reduced. If
at any time the outstanding shares of Common Stock of the
Company are
combined into a smaller number of shares, the Exercise Price in
effect
immediately prior to such combination shall be proportionately
increased.
1
<PAGE>
(b) Whenever the Exercise Price payable upon exercise of
this
Warrant is adjusted pursuant to this Section 2, the number of
Shares
purchasable upon exercise hereof simultaneously shall be
adjusted by
multiplying the number of Shares issuable immediately prior to
such
adjustment by the Exercise Price in effect immediately prior to
such
adjustment and dividing the product so obtained by the Exercise
Price, as
adjusted.
(c) the Company shall give notice to the Holder of any event
or
transaction that results in an adjustment in the Exercise Price,
within
ten (10) business days thereof, at the Holder's address as it
appears on
the books of the Company, including a computation of such
adjustment and
any adjustment in the number of Shares for which the Holder may
exercise
this Warrant and any further information as shall be necessary
to confirm
the computation of such adjustments.
(d) So long as this Warrant is outstanding, if (i) the Company
pays
any dividend or makes any distribution upon the Common Stock,
(ii) the
Company offers to the holders of the Common Stock for
subscription or
purchase by them any share of any class of capital stock or any
other
rights or (iii) any capital reorganization of the Company,
reclassification of the capital stock of the Company,
consolidation,
merger or other business combination of the Company with or into
another
entity, sale, lease or transfer of all or substantially all of
the assets
of the Company to another entity, or voluntary or involuntary
dissolution,
liquidation or winding up of the Company shall be effected, then
in any
such case, the Company shall cause to be mailed by certified
mail to the
Holder, at least ten (10) days prior to the date specified in
clause (x)
or (y) below, as the case may be, a notice containing a brief
description
of the proposed action and stating the date on which (x) a
record date
shall be established for the purpose of such dividend,
distribution or
rights offering or (y) such reclassification,
reorganization,
consolidation, merger, conveyance, sale, lease, transfer,
dissolution,
liquidation or winding up shall take place and the date, if any
to be
fixed, as of which the holders of Common Stock or other
securities shall
receive cash or other property deliverable upon such
reclassification,
reorganization, consolidation, merger, conveyance,
dissolution,
liquidation or winding up.
3. EXERCISE AND PAYMENT.
3.1 CASH EXERCISE. At any time after the Commencement Date,
this
Warrant may be exercised, in whole or in part, from time to time
by the Holder,
during the term hereof, by surrender of this Warrant and the
Notice of Exercise
annexed hereto duly completed and executed by the Holder to the
Company at the
principal executive offices of the Company, together with
payment in the amount
of the Exercise Price then in effect, as designated in the
Notice of Exercise.
Payment may be in cash or by check payable to the order of the
Company.
3.2 NET ISSUANCE. In lieu of payment of the Exercise Price
described
in Section 3.1, the Holder may elect to receive, without the
payment by the
Holder of any additional consideration, Shares equal to the
value of this
Warrant or any portion hereof by the surrender of this Warrant
or such portion
to the Company, with the net issue election notice annexed
hereto (the "NET
ISSUANCE ELECTION NOTICE") duly executed, at the office of the
Company.
Thereupon, the Company shall issue to the Holder such number of
fully paid and
nonassessable Shares as is computed using the following
formula:
2
<PAGE>
where: X = Y (A-B)
-------
A
X = the number of Shares to be issued to the Holder pursuant
to
this Section 3.
Y = the number of Shares covered by this Warrant in respect
of
which the net issuance election is made pursuant to this
Section 3.
A = the fair market value of one Share, as determined in
accordance with the provisions of this Section 3.
B = the Exercise Price in effect under this Warrant at the
time
the net issuance election is made pursuant to this Section
3.
For purposes of this Section 3, the "fair market value" per
Share shall mean:
i. If the class of Shares is traded on a national securities
exchange or is listed on the Nasdaq National Market (the
"NNM")
or other over-the-counter quotation system, the fair market
value
shall be the last reported sale price of a Share on such
exchange
or on the NNM or other over-the-counter quotation system on
the
last business day before the effective date of exercise of
the
net issuance election or if no such sale is made on such day,
the
mean of the closing bid and asked prices for such day on
such
exchange, the NNM or over-the-counter quotation system; and
ii. If the class of Shares is not so listed and bid and ask
prices are not reported, the fair market value shall be the
price
per Share which the Company could obtain from a willing buyer
for
Shares sold by the Company, as such price shall be determined
in
good faith by the Company's Board of Directors.
3.3 NO PARTIAL EXERCISE. This Warrant, if exercised, may only
be
exercised as to the full number of Shares that may be permitted
to be purchased
at the time of exercise. No partial exercises are permitted.
4. DELIVERY OF CERTIFICATES. Within five (5) business days after
exercise,
in whole or in part, of this Warrant, the Company shall issue in
the name of and
deliver to the Holder, a certificate or certificates for the
number of fully
paid and nonassessable Shares which the Holder shall have
requested in the
Notice of Exercise or Net Issuance Election Notice. If this
Warrant is exercised
in part, the Company shall deliver to the Holder a new Warrant
for the
unexercised portion of this Warrant at the time of delivery of
such certificate
or certificates.
5. NO FRACTIONAL SHARES. No fractional Shares or scrip
representing
fractional Shares will be issued upon exercise of this Warrant.
If upon any
exercise of this Warrant a fraction of a Share results, the
Company will pay the
Holder the difference between the cash value of the fractional
Share and the
portion of the Exercise Price allocable to the fractional
Share.
3
<PAGE>
6. CHARGES, TAXES AND EXPENSES. The Holder shall pay all
transfer taxes or
other incidental charges, if any, in connection with the
transfer of the Shares
purchased pursuant to the exercise hereof from the Company to
the Holder.
7. LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT. Upon
receipt by the
Company of evidence reasonably satisfactory to it of the loss,
theft,
destruction or mutilation of this Warrant, and in case of loss,
theft or
destruction, of indemnity or security reasonably satisfactory to
the Company,
and upon reimbursement to the Company of all reasonable expenses
incidental
thereto, and upon surrender and cancellation of this Warrant, if
mutilated, the
Company will make and deliver a new Warrant of like tenor and
dated as of such
cancellation, in lieu of this Warrant.
8. RIGHTS AS SHAREHOLDER. Prior to exercise of this Warrant, the
Holder
shall not be entitled to any rights as a shareholder of the
Company with respect
to the Shares, including (without limitation) the right to vote
such Shares,
receive dividends or other distributions thereon, or be notified
of Shareholder
meetings, and the Holder shall not be entitled to any notice or
other
communication concerning the business or affairs of the Company.
However, in the
event of any taking by the Company of a record of the holders of
any class of
securities for the purpose of determining the holders thereof
who are entitled
to receive any dividend (other than a cash dividend) or other
distribution, any
right to subscribe for, purchase or otherwise acquire any Common
Stock or any
other securities or property, or to receive any other right, the
Company shall
mail to each Holder of this Warrant, at least ten (10) days
prior to the date
specified therein, a notice specifying the date on which any
such record is to
be taken for the purpose of such dividend, distribution or
right, and the amount
and character of such dividend, distribution or right.
9. RESTRICTED SECURITIES. The Holder understands that this
Warrant and the
Shares purchasable hereunder constitute "restricted securities"
under the
federal securities laws inasmuch as they are, or will be,
acquired from the
Company in transactions not involving a public offering and
accordingly may not,
under such laws and applicable regulations, be resold or
transferred without
registration under the Securities Act of 1933 (the "1933 ACT")
or an applicable
exemption from such registration. In this connection, the Holder
acknowledges
that Rule 144 of the Securities and Exchange Commission (the
"SEC") is not now,
and may not in the future be, available for resale of the
Warrant and the Shares
purchasable hereunder. Unless the Shares are subsequently
registered, the Holder
further acknowledges that the securities legend on Exhibit A to
the Notice of
Exercise attached hereto shall be placed on any Shares issued to
the Holder upon
exercise of this Warrant.
10. CERTIFICATION OF INVESTMENT PURPOSE. Unless a current
registration
statement under the 1933 Act is in effect with respect to the
securities to be
issued upon exercise of this Warrant, the Holder covenants and
agrees that, at
the time of exercise hereof, he will deliver to the Company a
written
certification executed by the Holder that the securities
acquired by such Holder
upon exercise hereof are for the account of such Holder and
acquired for
investment purposes only and that such securities are not
acquired with a view
to, or for sale in connection with, any distribution
thereof.
4
<PAGE>
11. TRANSFERABILITY. This Warrant shall be transferable by the
Holder
subject to compliance with law.
12. MISCELLANEOUS.
12.1 CONSTRUCTION. Unless the context indicates otherwise, the
term
"Holder" shall include any transferee or transferees of this
Warrant, and the
term "Warrant" shall include any and all warrants outstanding
pursuant to this
Agreement, including those evidenced by a certificate or
certificates issued
upon division, exchange, substitution or transfer.
12.2 RESTRICTIONS. By receipt of this Warrant, the Holder makes
the
same representations with respect to the acquisition of this
Warrant as the
Holder is required to make upon the exercise of this Warrant and
acquisition of
the Shares purchasable hereunder as set forth in the Form of
Investment Letter
attached as Exhibit A to the Notice of Exercise attached
hereto.
12.3 NOTICES. Unless otherwise provided, any notice required
or
permitted under this Warrant shall be given in writing and shall
be deemed
effectively given upon personal delivery to the party to be
notified or three
(3) days following deposit with the United States Post Office,
by registered or
certified mail, postage prepaid and addressed to the party to be
notified (or
one (1) day following timely deposit with a reputable overnight
courier with
next day delivery instructions), or upon confirmation of receipt
by the sender
of any notice by facsimile transmission, at the address
indicated below or at
such other address as such party may designate by ten (10) days'
advance written
notice to the other parties.
If to the Company, addressed to: Integrated Healthcare Holdings,
Inc.
695 Town Center Drive, Suite 260
Costa Mesa, CA 92626
Attention: Chief Executive Officer
If to the Holder, addressed to: c/o Strategic Global Management,
Inc.
6800 Indiana Avenue, Suite 130
Riverside, CA 92506
Attention: William E. Thomas, Esq.
12.4 GOVERNING LAW. This Warrant shall be governed by and
construed
under the laws of the State of California as applied to
agreements among
California residents entered into and to be performed entirely
within
California.
12.5 ENTIRE AGREEMENT. This Warrant, the exhibits and
schedules
hereto, and the documents referred to herein, constitute the
entire agreement
and understanding of the parties hereto with respect to the
subject matter
hereof, and supersede all prior and contemporaneous agreements
and
understandings, whether oral or written, between the parties
hereto with respect
to the subject matter hereof.
5
<PAGE>
12.6 BINDING EFFECT. This Warrant and the various rights and
obligations arising hereunder shall inure to the benefit of and
be binding upon
the Company and its successors and assigns, and Holder and its
successors and
assigns.
12.7 WAIVER; CONSENT. This Warrant may not be changed,
amended,
terminated, augmented, rescinded or discharged (other than by
performance), in
whole or in part, except by a writing executed by the parties
hereto, and no
waiver of any of the provisions or conditions of this Warrant or
any of the
rights of a party hereto shall be effective or binding unless
such waiver shall
be in writing and signed by the party claimed to have given or
consented
thereto.
12.8 SEVERABILITY. If one or more provisions of this Warrant
are
held to be unenforceable under applicable law, such provision
shall be excluded
from this Warrant and the balance of the Warrant shall be
interpreted as if such
provision were so excluded and the balance shall be enforceable
in accordance
with its terms.
12.9 DISPUTE RESOLUTION. In the event of any dispute arising out
of
or relating to this Warrant, such dispute shall be resolved
solely and
exclusively by confidential binding arbitration with the Orange
County branch of
JAMS ("JAMS") to be governed by JAMS' Commercial Rules of
Arbitration in effect
at the time of the commencement of the arbitration (the "JAMS
RULES") and heard
before one arbitrator. The parties shall attempt to mutually
select the
arbitrator. In the event they are unable to mutually agree, the
arbitrator shall
be selected by the procedures prescribed by the JAMS Rules. Each
party shall
bear its own attorneys' fees, expert witness fees, and costs
incurred in
connection with any arbitration.
IN WITNESS WHEREOF, the parties have executed this Warrant as of
the date
first above written.
"HOLDER": -----------------------------------------
KALI P. CHAUDHURI, M.D., an individual
"COMPANY": INTEGRATED HEALTHCARE HOLDINGS,
INC., a Nevada corporation
By:
--------------------------------------
Larry B. Anderson, President
6
<PAGE>
NOTICE OF EXERCISE
To: INTEGRATED HEALTHCARE HOLDINGS, INC.
The undersigned hereby elects to purchase _____________ shares
of
_________ Stock (the "Shares") of Integrated Healthcare
Holdings, Inc., a Nevada
corporation (the "Company") pursuant to the terms of the
attached Warrant, and
tenders herewith payment of the purchase price pursuant to the
terms of the
Warrant.
Attached as Exhibit A is an investment representation letter
addressed to the Company and executed by the undersigned as
required by Section
10 of the Warrant.
Please issue certificates representing the Common Stock
purchased
hereunder in the names and in the denominations indicated on
Exhibit A attached
hereto.
Please issue a new Warrant for the unexercised portion of
the
attached Warrant, if any, in the name of the undersigned.
Dated:
--------------------------------
-----------------------------------
Name:
-----------------------------
Title:
-----------------------------
<PAGE>
NET ISSUANCE ELECTION NOTICE
To: INTEGRATED HEALTHCARE HOLDINGS, INC.
Date:_____________
The undersigned hereby elects under Section 3.2 of the attached
Warrant to
surrender the right to purchase ___________ shares of
___________ Stock (the
"Shares") pursuant to the attached Warrant. The Certificate(s)
for the Shares
issuable upon such net issuance election shall be issued in the
name of the
undersigned or as otherwise indicated below.
Attached as Exhibit A is an investment representation letter
addressed to
the Company and executed by the undersigned as required by
Section 10 of the
Warrant.
Please issue certificates representing the Shares purchased
hereunder in
the names and in the denominations indicated on Exhibit A
attached hereto.
Please issue a new Warrant for the unexercised portion of the
attached
Warrant, if any, in the name of the undersigned.
---------------------------
Signature
---------------------------
Name for Registration
---------------------------
Mailing Address
<PAGE>
EXHIBIT A
To: INTEGRATED HEALTHCARE HOLDINGS, INC.
In connection with the purchase by the undersigned of _________
shares of
Common Stock (the "SHARES") of Integrated Healthcare Holdings,
Inc., a Nevada
corporation (the "COMPANY"), upon exercise of that certain
Warrant dated as of
January 27, 2005, the undersigned hereby represents and warrants
as follows:
The Shares to be received by the undersigned upon exercise of
the Warrant
are being acquired for his own account, not as a nominee or
agent, and not with
a view to resale or distribution of any part thereof, and the
undersigned has no
present intention of selling, granting any participation in, or
otherwise
distributing the same. The undersigned further represents that
he does not have
any contract, undertaking, agreement or arrangement with any
person to sell,
transfer or grant participation to such person or to any third
person, with
respect to the Shares. The undersigned believes he has received
all the
information he considers necessary or appropriate for deciding
whether to
purchase the Shares.
The undersigned understands that the Shares are characterized
as
"restricted securities" under the federal securities laws
inasmuch as they are
being acquired from the Company in transactions not involving a
public offering
and that under such laws and applicable regulations such
securities may be
resold without registration under the Securities Act of 1933, as
amended (the
"ACT"), only in certain limited circumstances. In this
connection, the
undersigned represents that he is familiar with SEC Rule 144, as
presently in
effect, and understands the resale limitations imposed thereby
and by the Act.
Without in any way limiting the representations set forth above,
the
undersigned agrees not to make any disposition of all or any
portion of the
Shares unless and until:
There is then in effect a registration statement under the Act
covering
such proposed disposition and such disposition is made in
accordance with such
registration statement; or
(i) The undersigned has notified the Company of the proposed
disposition and shall have furnished the Company with a detailed
statement
of the circumstances surrounding the proposed disposition,
and
(ii) if requested, the undersigned has furnished the Company
with an
opinion of counsel, reasonably satisfactory to the Company that
such
disposition will not require registration of such shares under
the Act.
The Company will not require an opinion of counsel for sales
made pursuant
to Rule 144 except in unusual circumstances.
The undersigned understands the instruments evidencing the
Shares may bear
a legend similar to the following:
<PAGE>
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED
UNDER THE SECURITIES ACT OF 1933; THEY HAVE BEEN ACQUIRED BY THE
HOLDER FOR
INVESTMENT AND MAY NOT BE PLEDGED, HYPOTHECATED, SOLD,
TRANSFERRED OR OTHERWISE
DISPOSED OF EXCEPT AS MAY BE AUTHORIZED UNDER THE SECURITIES ACT
OF 1933, AND
THE RULES AND REGULATIONS PROMULGATED THEREUNDER.
Dated:
--------------------------------
------------------------------------
Name:
-----------------------------
Title:
-----------------------------
<PAGE>
EXHIBIT B-2
FORM OF
STOCK PURCHASE WARRANT
14,700,000 Shares January 27, 2005
This certifies that, for good and valuable consideration,
receipt of which
is hereby acknowledged, William E. Thomas (the "HOLDER") is
entitled to
purchase, subject to the terms and conditions of this Warrant,
from Integrated
Healthcare Holdings, Inc, a Nevada corporation (the "COMPANY"),
Fourteen
Million, Seven Hundred Thousand (14,700,000) shares of the
Company's common
stock (the "SHARES") in accordance with Section 3 during the
period commencing
on the second anniversary of the date hereof (the "COMMENCEMENT
DATE") and
ending at 5:00 p.m. California time, on the date which is three
and one-half (3
1/2) years from the date hereof (the "EXPIRATION DATE"), at
which time this
Warrant will expire and become void unless earlier terminated as
provided
herein. Notwithstanding the foregoing, this Warrant may not be
exercised in an
amount that would exceed, when added to the number of shares of
common stock of
the Company previously acquired by the Holder by virtue of
exercise of this
Warrant (or any replacement Warrant), four and nine-tenths
percent (4.9%) of the
total number of outstanding shares of capital stock of the
Company on a
Fully-Diluted basis on the date of exercise. Capitalized terms
used herein
without definition have the meanings ascribed to them in the
Rescission,
Restructuring and Assignment Agreement of even date herewith by
and among the
Company, the Holder and certain other parties thereto.
1. VESTING AND EXERCISE PRICE.
(a) The right to exercise this Warrant shall fully vest on
the
Commencement Date.
(b) The exercise or purchase price for the first 8,461,847
Shares
purchased upon exercise of this Warrant shall be $0.003125 per
Share, and
the exercise or purchase price for the remainder of the Shares
shall be
$0.078 per Share if exercised between January 27, 2007 and July
26, 2007,
$0.11 per Share if exercised between July 27, 2007 and January
26, 2008,
and $0.15 thereafter, all subject to adjustment as provided in
Section 2
(the "EXERCISE PRICE").
2. ANTI-DILUTION PROVISIONS. The Exercise Price in effect at any
time and
the number of Shares purchasable upon the exercise of this
Option shall be
subject to adjustment from time to time upon the happening of
any of the
following events:
(a) If at any time the Company subdivides its outstanding shares
of
Common Stock into a greater number of shares, the Exercise Price
in effect
immediately prior to such subdivision shall be proportionately
reduced. If
at any time the outstanding shares of Common Stock of the
Company are
combined into a smaller number of shares, the Exercise Price in
effect
immediately prior to such combination shall be proportionately
increased.
1
<PAGE>
(b) Whenever the Exercise Price payable upon exercise of
this
Warrant is adjusted pursuant to this Section 2, the number of
Shares
purchasable upon exercise hereof simultaneously shall be
adjusted by
multiplying the number of Shares issuable immediately prior to
such
adjustment by the Exercise Price in effect immediately prior to
such
adjustment and dividing the product so obtained by the Exercise
Price, as
adjusted.
(c) the Company shall give notice to the Holder of any event
or
transaction that results in an adjustment in the Exercise Price,
within
ten (10) business days thereof, at the Holder's address as it
appears on
the books of the Company, including a computation of such
adjustment and
any adjustment in the number of Shares for which the Holder may
exercise
this Warrant and any further information as shall be necessary
to confirm
the computation of such adjustments.
(d) So long as this Warrant is outstanding, if (i) the Company
pays
any dividend or makes any distribution upon the Common Stock,
(ii) the
Company offers to the holders of the Common Stock for
subscription or
purchase by them any share of any class of capital stock or any
other
rights or (iii) any capital reorganization of the Company,
reclassification of the capital stock of the Company,
consolidation,
merger or other business combination of the Company with or into
another
entity, sale, lease or transfer of all or substantially all of
the assets
of the Company to another entity, or voluntary or involuntary
dissolution,
liquidation or winding up of the Company shall be effected, then
in any
such case, the Company shall cause to be mailed by certified
mail to the
Holder, at least ten (10) days prior to the date specified in
clause (x)
or (y) below, as the case may be, a notice containing a brief
description
of the proposed action and stating the date on which (x) a
record date
shall be established for the purpose of such dividend,
distribution or
rights offering or (y) such reclassification,
reorganization,
consolidation, merger, conveyance, sale, lease, transfer,
dissolution,
liquidation or winding up shall take place and the date, if any
to be
fixed, as of which the holders of Common Stock or other
securities shall
receive cash or other property deliverable upon such
reclassification,
reorganization, consolidation, merger, conveyance,
dissolution,
liquidation or winding up.
3. EXERCISE AND PAYMENT.
3.1 CASH EXERCISE. At any time after the Commencement Date,
this
Warrant may be exercised, in whole or in part, from time to time
by the Holder,
during the term hereof, by surrender of this Warrant and the
Notice of Exercise
annexed hereto duly completed and executed by the Holder to the
Company at the
principal executive offices of the Company, together with
payment in the amount
of the Exercise Price then in effect, as designated in the
Notice of Exercise.
Payment may be in cash or by check payable to the order of the
Company.
3.2 NET ISSUANCE. In lieu of payment of the Exercise Price
described
in Section 3.1, the Holder may elect to receive, without the
payment by the
Holder of any additional consideration, Shares equal to the
value of this
Warrant or any portion hereof by the surrender of this Warrant
or such portion
to the Company, with the net issue election notice annexed
hereto (the "NET
ISSUANCE ELECTION NOTICE") duly executed, at the office of the
Company.
Thereupon, the Company shall issue to the Holder such number of
fully paid and
nonassessable Shares as is computed using the following
formula:
2
<PAGE>
where: X = Y (A-B)
-------
A
X = the number of Shares to be issued to the Holder pursuant
to
this Section 3.
Y = the number of Shares covered by this Warrant in respect
of
which the net issuance election is made pursuant to this
Section 3.
A = the fair market value of one Share, as determined in
accordance with the provisions of this Section 3.
B = the Exercise Price in effect under this Warrant at the
time
the net issuance election is made pursuant to this Section
3.
For purposes of this Section 3, the "fair market value" per
Share shall mean:
i. If the class of Shares is traded on a national securities
exchange or is listed on the Nasdaq National Market (the
"NNM")
or other over-the-counter quotation system, the fair market
value
shall be the last reported sale price of a Share on such
exchange
or on the NNM or other over-the-counter quotation system on
the
last business day before the effective date of exercise of
the
net issuance election or if no such sale is made on such day,
the
mean of the closing bid and asked prices for such day on
such
exchange, the NNM or over-the-counter quotation system; and
ii. If the class of Shares is not so listed and bid and ask
prices are not reported, the fair market value shall be the
price
per Share which the Company could obtain from a willing buyer
for
Shares sold by the Company, as such price shall be determined
in
good faith by the Company's Board of Directors.
3.3 NO PARTIAL EXERCISE. This Warrant, if exercised, may only
be
exercised as to the full number of Shares that may be permitted
to be purchased
at the time of exercise. No partial exercises are permitted.
4. DELIVERY OF CERTIFICATES. Within five (5) business days after
exercise,
in whole or in part, of this Warrant, the Company shall issue in
the name of and
deliver to the Holder, a certificate or certificates for the
number of fully
paid and nonassessable Shares which the Holder shall have
requested in the
Notice of Exercise or Net Issuance Election Notice. If this
Warrant is exercised
in part, the Company shall deliver to the Holder a new Warrant
for the
unexercised portion of this Warrant at the time of delivery of
such certificate
or certificates.
5. NO FRACTIONAL SHARES. No fractional Shares or scrip
representing
fractional Shares will be issued upon exercise of this Warrant.
If upon any
exercise of this Warrant a fraction of a Share results, the
Company will pay the
Holder the difference between the cash value of the fractional
Share and the
portion of the Exercise Price allocable to the fractional
Share.
3
<PAGE>
6. CHARGES, TAXES AND EXPENSES. The Holder shall pay all
transfer taxes or
other incidental charges, if any, in connection with the
transfer of the Shares
purchased pursuant to the exercise hereof from the Company to
the Holder.
7. LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT. Upon
receipt by the
Company of evidence reasonably satisfactory to it of the loss,
theft,
destruction or mutilation of this Warrant, and in case of loss,
theft or
destruction, of indemnity or security reasonably satisfactory to
the Company,
and upon reimbursement to the Company of all reasonable expenses
incidental
thereto, and upon surrender and cancellation of this Warrant, if
mutilated, the
Company will make and deliver a new Warrant of like tenor and
dated as of such
cancellation, in lieu of this Warrant.
8. RIGHTS AS SHAREHOLDER. Prior to exercise of this Warrant, the
Holder
shall not be entitled to any rights as a shareholder of the
Company with respect
to the Shares, including (without limitation) the right to vote
such Shares,
receive dividends or other distributions thereon, or be notified
of Shareholder
meetings, and the Holder shall not be entitled to any notice or
other
communication concerning the business or affairs of the Company.
However, in the
event of any taking by the Company of a record of the holders of
any class of
securities for the purpose of determining the holders thereof
who are entitled
to receive any dividend (other than a cash dividend) or other
distribution, any
right to subscribe for, purchase or otherwise acquire any Common
Stock or any
other securities or property, or to receive any other right, the
Company shall
mail to each Holder of this Warrant, at least ten (10) days
prior to the date
specified therein, a notice specifying the date on which any
such record is to
be taken for the purpose of such dividend, distribution or
right, and the amount
and character of such dividend, distribution or right.
9. RESTRICTED SECURITIES. The Holder understands that this
Warrant and the
Shares purchasable hereunder constitute "restricted securities"
under the
federal securities laws inasmuch as they are, or will be,
acquired from the
Company in transactions not involving a public offering and
accordingly may not,
under such laws and applicable regulations, be resold or
transferred without
registration under the Securities Act of 1933 (the "1933 ACT")
or an applicable
exemption from such registration. In this connection, the Holder
acknowledges
that Rule 144 of the Securities and Exchange Commission (the
"SEC") is not now,
and may not in the future be, available for resale of the
Warrant and the Shares
purchasable hereunder. Unless the Shares are subsequently
registered, the Holder
further acknowledges that the securities legend on Exhibit A to
the Notice of
Exercise attached hereto shall be placed on any Shares issued to
the Holder upon
exercise of this Warrant.
10. CERTIFICATION OF INVESTMENT PURPOSE. Unless a current
registration
statement under the 1933 Act is in effect with respect to the
securities to be
issued upon exercise of this Warrant, the Holder covenants and
agrees that, at
the time of exercise hereof, he will deliver to the Company a
written
certification executed by the Holder that the securities
acquired by such Holder
upon exercise hereof are for the account of such Holder and
acquired for
investment purposes only and that such securities are not
acquired with a view
to, or for sale in connection with, any distribution
thereof.
4
<PAGE>
11. TRANSFERABILITY. This Warrant shall be transferable by the
Holder
subject to compliance with law.
12. MISCELLANEOUS.
12.1 CONSTRUCTION. Unless the context indicates otherwise, the
term
"Holder" shall include any transferee or transferees of this
Warrant, and the
term "Warrant" shall include any and all warrants outstanding
pursuant to this
Agreement, including those evidenced by a certificate or
certificates issued
upon division, exchange, substitution or transfer.
12.2 RESTRICTIONS. By receipt of this Warrant, the Holder makes
the
same representations with respect to the acquisition of this
Warrant as the
Holder is required to make upon the exercise of this Warrant and
acquisition of
the Shares purchasable hereunder as set forth in the Form of
Investment Letter
attached as Exhibit A to the Notice of Exercise attached
hereto.
12.3 NOTICES. Unless otherwise provided, any notice required
or
permitted under this Warrant shall be given in writing and shall
be deemed
effectively given upon personal delivery to the party to be
notified or three
(3) days following deposit with the United States Post Office,
by registered or
certified mail, postage prepaid and addressed to the party to be
notified (or
one (1) day following timely deposit with a reputable overnight
courier with
next day delivery instructions), or upon confirmation of receipt
by the sender
of any notice by facsimile transmission, at the address
indicated below or at
such other address as such party may designate by ten (10) days'
advance written
notice to the other parties.
If to the Company, addressed to: Integrated Healthcare Holdings,
Inc.
695 Town Center Drive, Suite 260
Costa Mesa, CA 92626
Attention: Chief Executive Officer
If to the Holder, addressed to: c/o Strategic Global Management,
Inc.
6800 Indiana Avenue, Suite 130
Riverside, CA 92506
Attention: William E. Thomas, Esq.
12.4 GOVERNING LAW. This Warrant shall be governed by and
construed
under the laws of the State of California as applied to
agreements among
California residents entered into and to be performed entirely
within
California.
12.5 ENTIRE AGREEMENT. This Warrant, the exhibits and
schedules
hereto, and the documents referred to herein, constitute the
entire agreement
and understanding of the parties hereto with respect to the
subject matter
hereof, and supersede all prior and contemporaneous agreements
and
understandings, whether oral or written, between the parties
hereto with respect
to the subject matter hereof.
5
<PAGE>
12.6 BINDING EFFECT. This Warrant and the various rights and
obligations arising hereunder shall inure to the benefit of and
be binding upon
the Company and its successors and assigns, and Holder and its
successors and
assigns.
12.7 WAIVER; CONSENT. This Warrant may not be changed,
amended,
terminated, augmented, rescinded or discharged (other than by
performance), in
whole or in part, except by a writing executed by the parties
hereto, and no
waiver of any of the provisions or conditions of this Warrant or
any of the
rights of a party hereto shall be effective or binding unless
such waiver shall
be in writing and signed by the party claimed to have given or
consented
thereto.
12.8 SEVERABILITY. If one or more provisions of this Warrant
are
held to be unenforceable under applicable law, such provision
shall be excluded
from this Warrant and the balance of the Warrant shall be
interpreted as if such
provision were so excluded and the balance shall be enforceable
in accordance
with its terms.
12.9 DISPUTE RESOLUTION. In the event of any dispute arising out
of
or relating to this Warrant, such dispute shall be resolved
solely and
exclusively by confidential binding arbitration with the Orange
County branch of
JAMS ("JAMS") to be governed by JAMS' Commercial Rules of
Arbitration in effect
at the time of the commencement of the arbitration (the "JAMS
RULES") and heard
before one arbitrator. The parties shall attempt to mutually
select the
arbitrator. In the event they are unable to mutually agree, the
arbitrator shall
be selected by the procedures prescribed by the JAMS Rules. Each
party shall
bear its own attorneys' fees, expert witness fees, and costs
incurred in
connection with any arbitration.
IN WITNESS WHEREOF, the parties have executed this Warrant as of
the date
first above written.
"HOLDER": -----------------------------------------
WILLIAM E. THOMAS, an individual
"COMPANY": INTEGRATED HEALTHCARE HOLDINGS, INC.,
a Nevada corporation
By:
--------------------------------------
Larry B. Anderson, President
6
<PAGE>
NOTICE OF EXERCISE
To: INTEGRATED HEALTHCARE HOLDINGS, INC.
The undersigned hereby elects to purchase _____________ shares
of
_________ Stock (the "Shares") of Integrated Healthcare
Holdings, Inc., a Nevada
corporation (the "Company") pursuant to the terms of the
attached Warrant, and
tenders herewith payment of the purchase price pursuant to the
term
|